These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3544488)

  • 21. Extracellular proteases as targets for treatment of cancer metastases.
    Lee M; Fridman R; Mobashery S
    Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoscale imaging and quantification of local proteolytic activity.
    Kusick S; Bertram H; Oberleithner H; Ludwig T
    J Cell Physiol; 2005 Sep; 204(3):767-74. PubMed ID: 15744770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some unusual manifestations of proteolysis.
    Nikandrov VN; Pyzhova NS
    Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):30-9. PubMed ID: 17543196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis.
    Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ
    Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein degradation in cell cultures: general considerations on mechanisms and regulation.
    Dean RT
    Fed Proc; 1980 Jan; 39(1):15-9. PubMed ID: 6985868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
    Palmeira VF; Kneipp LF; Alviano CS; dos Santos AL
    Res Microbiol; 2006 Nov; 157(9):819-26. PubMed ID: 16959473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human tetranectin: methodological and clinical studies.
    Høgdall CK
    APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Proteolytic enzymes of the fungi: extracellular proteases of xylotrophic basidiomycetes].
    Kudriavtseva OA; Dunaevskiĭ IaE; Kamzolkina OV; Belozerskiĭ MA
    Mikrobiologiia; 2008; 77(6):725-37. PubMed ID: 19137711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice.
    Rofstad EK; Mathiesen B; Kindem K; Galappathi K
    Cancer Res; 2006 Jul; 66(13):6699-707. PubMed ID: 16818644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).
    Wyganowska-Świątkowska M; Tarnowski M; Murtagh D; Skrzypczak-Jankun E; Jankun J
    Int J Mol Med; 2019 Jan; 43(1):15-25. PubMed ID: 30431071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.
    Schmitt M; Harbeck N; Thomssen C; Wilhelm O; Magdolen V; Reuning U; Ulm K; Höfler H; Jänicke F; Graeff H
    Thromb Haemost; 1997 Jul; 78(1):285-96. PubMed ID: 9198168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Limited proteolysis activation syndrome in surgery].
    Chalenko VV
    Vestn Khir Im I I Grek; 1990 Aug; 145(8):41-5. PubMed ID: 2177262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General biological aspects of tumor formation. I. Role of indole compounds].
    Artamonov VI
    Usp Sovrem Biol; 1973; 75(3):441-51. PubMed ID: 4581561
    [No Abstract]   [Full Text] [Related]  

  • 35. Proteolytic enzymes in experimental rat pancreatitis.
    Huttunen R
    Ann Med Exp Biol Fenn; 1973; 51(4):133-8. PubMed ID: 4787806
    [No Abstract]   [Full Text] [Related]  

  • 36. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mitochondrial proteinase of yeast splitting the products of mitochondrial translation].
    Kal'nov SL; Novikova LA; Zubatov AS; Luzikov VN
    Biokhimiia; 1980 Feb; 45(2):355-62. PubMed ID: 6992875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy.
    Wright JA; Turley EA; Greenberg AH
    Crit Rev Oncog; 1993; 4(5):473-92. PubMed ID: 8241321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of IgE binding to beta-lactoglobulin by fermentation and proteolysis of cow's milk.
    Ehn BM; Allmere T; Telemo E; Bengtsson U; Ekstrand B
    J Agric Food Chem; 2005 May; 53(9):3743-8. PubMed ID: 15853429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perforated hepatocytes as a system for studying intracellular proteolysis.
    Grinde B; Hungnes O; Gravningen M
    Biomed Biochim Acta; 1986; 45(11-12):1627-33. PubMed ID: 3555477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.